AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 251 min read$IHT

WIRTH JAMES F sold $52K of IHT

WIRTH JAMES F (President & CEO) sold 34,800 shares of INNSUITES HOSPITALITY TRUST (IHT) at $1.50 on 2026-08-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · WIRTH JAMES F
Published Aug 25, 2026, 12:27 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 12:38 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$IHT
Neutral
high confidence
Mentioned
$IHT
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IHTNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to affect IHT's valuation.

02

Market read

Primary insider sale with low materiality; limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 2/10Novelty 4/10Timing: post-market filing

Background

Form 4 filings provide the first public record of insider transactions.

Company-level read

Ticker impact

$IHTNeutralHigh confidence
Context

Form 4 disclosed President & CEO James Wirth sold 34,800 shares for $52,318, a primary insider sale.

Expected impact

Minimal short-term price effect.

Evidence & confidence

Sale amount is under $100k and represents a tiny fraction of holdings; unlikely to move the stock.

Market effects

Sector

None significant for the REIT sector.

Regional

No regional impact.

Global

Limited to investors tracking insider activity.

Counterpoint

What could challenge this read

Insider could be reallocating capital; not necessarily negative.

Key entities

  • Officer
    James Wirth

    President & CEO of IHT, 10% owner.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

IHT insider trading history →

Related articles

OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min